POLYPROX
LIVE

Serial Number

79281280

Owner

PolyProx Therapeutics Ltd

Filing Date

Jan 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

POLYPROX Trademark

Serial Number: 79281280 • Registration: 6344063

POLYPROX is a trademark filed by PolyProx Therapeutics Ltd on January 30, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PolyProx Therapeutics Ltd (2 trademarks)

Jonas Webb Building (B910),

Entity Type: 99

Laura Susan Itzhaki (2 trademarks)

50 High Street,

Entity Type: 98

Trademark Details

Filing Date

January 30, 2020

Registration Date

May 11, 2021

Published for Opposition

February 23, 2021

Goods & Services

Pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancers, neurological diseases, metabolic diseases, cardiovascular diseases, autoimmune and inflammatory diseases; pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancer, including lung, colorectal and pancreatic cancers

Chemicals, chemical compounds and biologic compounds for use in industry and science; chemicals, chemical compounds and biologic compounds for use in industry and science, other than for medical or veterinary use; chemicals, chemical compounds and biologic compounds for scientific, laboratory or research purposes, in particular for use in the manufacture of pharmaceuticals and drugs for the treatment of cancer, including lung, colorectal and pancreatic cancers

Medical services; medical services connected with the treatment of cancer, including lung, colorectal and pancreatic cancers

Scientific and technological services, namely, scientific research, analysis, design and testing in the field of pharmaceuticals, drugs and pharmaceutical preparations; drug discovery and drug development services; conducting or providing research and development services for others in the field of pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancer, including lung, colorectal and pancreatic cancers

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Mar 4, 2022 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 25, 2021 FICS
FINAL DISPOSITION PROCESSED
Aug 25, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 11, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
May 11, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 23, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Feb 20, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 3, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 3, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2021 CRFA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 27, 2020 ADCH
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2020 TROA
REFUSAL PROCESSED BY IB
May 22, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
May 4, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 22, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 21, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 18, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 27, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 19, 2020 REPR